Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C

Journal of Immunoassay and Immunochemistry

Volumn 28, Issue 4, 2007, Pages 331-342

  Attallah, Abdelfattah M ^a   Zahran, Faten ^a   Ismail, Hisham ^a   Omran, Mohamed M ^a   El Dosoky, Ibrahim ^b   Shiha, Gamal E ^b  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Biomarkers; Fibronectin; Fibrosis; HCV

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SERUM; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 34548834736     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701603476     Document Type: Article

References (38)

1. Bataller, R.; Brenner, D.A. Liver fibrosis. J. Clin. Invest. 2005, 115 (4), 209-218.
2. Asselah, T.; Bieche, I.; Paradis, V.; Bedossa, P.; Vidaud, M.; Marcellin, P. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. Semin. Liver Dis. 2007, 27 (1), 13-27.
3. Kawamoto, M.; Mizuguchi, T.; Katsuramaki, T.; Nagayama, M.; Oshima, H.; Kawasaki, H.; Nobuoka, T.; Kimura, Y.; Hirata, K. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J. Gastroenterol. 2006, 12 (27), 4325-4330.
4. Guechot, J.; Poupon, R.E.; Giral, P.; Balkau, B.; Giboudeau, J.; Poupon, R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J. Hepatol. 1994, 20 (3), 388-393.
5. Hirata, R. Predictive value of serum aminoterminal type III procollagen peptide levels, serum laminin levels, and liver membrane antibodies for prognosis of chronic hepatitis. Nippon. Shokakibyo. Gakkai. Zasshi. 1989, 86 (4), 905-912.
6. Arthur, M.J. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279 (2), G245-G249.
7. Parkar, M.H.; Bakalios, P.; Newman, H.N.; Olsen, I. Expression and splicing of the fibronectin gene in healthy and diseased periodontal tissue. Eur. J. Oral Sci. 1997, 105 (3), 264-270.
8. Matsui, S.; Takahashi, T.; Oyanagi, Y.; Takahashi, S.; Boku, S.; Takahashi, K.; Furukawa, K.; Arai, F.; Asakura, H. Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma. J. Hepatol. 1997, 27 (5), 843-853.
9. Gutman, A.; Kornblihtt, A.R. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc. Natl. Acad. Sci. USA 1987, 84 (20), 7179-7182.
10. Stathakis, N.E.; Fountas, A.; Tsianos, E. Plasma fibronectin in normal subjects and in various disease states. J. Clin. Pathol. 1981, 34 (5), 504-508.
11. Muro, A.F.; Chauhan, A.K.; Gajovic, S.; Iaconcig, A.; Porro, F.; Stanta, G.; Baralle, F.E. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 2003, 162 (1), 149-160.
12. Dufour, S.; Duband, J.L.; Kornblihtt, A.R.; Thiery, J.P. The role of fibronectins in embryonic cell migrations. Trend. Genet. 1988, 4 (7), 198-203.
13. Dufour, S.; Duband, J.L.; Humphries, M.J.; Obara, M.; Yamada, K.; Thiery, J.P. Attachment, spreading and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules. EMBO. J. 1988, 7 (9), 2661-2671.
14. Proctor, R.A. Fibronectin: a brief overview of its structure, function, and physiology. Rev. Infect. Dis. 1987, 9 (4), S317-S321.
15. Attallah, A.M.; Ismail, H.; Tabll, A.; Shiha, G.E.; El-Dosoky, I. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection. J. Immunoassay Immunochem. 2003, 24 (4), 395-407.
16. Attallah, A.M.; Shiha, G.E.; Abdel Malak, C.A.; Hagras, H.E.; Abdel-Razik, W.S.; Ismail, H. Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV-infected individuals with pegylated interferon α-2a. Hepatol. Res. 2004, 28 (2), 68-72.
17. Poynard, T.; Bedossa, P.; Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349 (9055), 825-832.
18. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227 (5259), 680-685.
19. Towbin, H.; Stachlin, T.; Gordou, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76 (9), 4350-4354.
20. Lowry, O.H.; Rosenbrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with folin - phenol reagent. J. Biol. Chem. 1951, 193 (1), 265-275.
21. Attallah, A.M.; Abdel Malak, C.A.; Elghawalby, N.A.; Shehatta, A.S.; Abdel-Raouf, M.; Shiha, G.E. Identification of a specific marker for hepatitis C virus infection using capillary zone electrophoresis. Clin. Chim. Acta 2004, 346 (2), 171-179.
22. Attallah, A.M.; Shiha, G.E.; Omran, M.M.; Zalata, K.R. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol. Res. 2006, 34 (3), 163-169.
23. Attallah, A.M.; Toson, el-S.A.; El-Waseef, A.M.; Abo-Seif, M.A.; Omran, M.M.; Shiha, G.E. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Clin. Chim. Acta 2006, 369 (1), 66-72.
24. Hynes, R.O. The role of fibronectin in cellular behavior. Results Probl. Cell Diff. 1980, 11, 112-123.
25. Tamkun, J.W.; Hynes, R.O. Plasma fibronectin is synthesized and secreted by hepatocytes. J. Biol. Chem. 1983, 258 (7), 4641-4647.
26. Albanis, E.; Friedman, S.L. Diagnosis of hepatic fibrosis in patients with chronic hepatitis C. Clin. Liver Dis. 2006, 10 (4), 821-833.
27. Fortunato, G.; Castaldo, G.; Oriani, G.; Cerini, R.; Intrieri, M.; Molinaro, E.; Gentile, I.; Borgia, G.; Piazza, M.; Salvatore, F.; Sacchetti, L. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin. Chem. 2001, 47 (9), 1696-1700.
28. Salcedo, R.; Wasserman, K.; Patarroyo, M. Endogenous fibronectin of blood polymorphonuclear leukocytes: stimulus-induced secretion and proteolysis by cell surface-bound elastase. Exp. Cell Res. 1997, 233 (1), 33-40.
29. Jagirdar, J.; Ishak, K.G.; Colombo, M.; Brambilla, C.; Paronetto, F. Fibronectin patterns in hepatocellular carcinoma and its clinical significance. Cancer 1985, 56 (7), 1643-1648.
30. Tsumagari, J. Fibronectin in human hepatocellular carcinoma (HCC) and HCC cell lines. Acta Pathol. Jpn. 1987, 37 (3), 413-423.
31. Torbenson, M.; Wang, J.; Choti, M.; Ashfaq, R.; Maitra, A.; Wilentz, R.E.; Boitnott, J. Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod. Pathol. 2002, 15 (8), 826-830.
32. Vuento, M.; Vaheri, A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem. J. 1979, 183 (2), 331-337.
33. Helvaci, M.; Ozkaya, B.; Ozbal, E.; Ozinel, S.; Yaprak, I. Efficacy of interferon therapy on serum fibronectin levels in children with chronic hepatitis B infection. Pediat. Int. 1999, 41 (3), 270-273.
34. Naveau, S.; Poynard, T.; Abella, A.; Pignon, J.P.; Poitrine, A.; Agostini, H.Zourabichvili O; Chaput, J.C. Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients. Hepatol. 1985, 5 (5), 819-823.
35. Junge, J.; Horn, T.; Christoffersen, P. The occurrence and significance of fibronectin in livers from chronic alcoholics. An immunohistochemical study of early alcoholic liver injury. APMIS 1988, 96 (1), 56-61.
36. Lackner, C.; Struber, G.; Liegl, B.; Leibl, S.; Ofner, P.; Bankuti, C.; Bauer, B.; Stauber, R.E. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatol. 2005, 41 (6), 1376-1382.
37. Cai, W.M.; Zhang, B.B.; Weng, H.L.; Hu, Z.R.; Lv, J.; Zheng, M.; Liu, R.H. The diagnostic value of eight serum indices for liver fibrosis. Zhonghua. Gan. Zang. Bing. Za. Zhi. 2004, 12 (4), 219-222.
38. Rossi, E.; Adams, L.; Prins, A.; Bulsara, M.; de Boer, B.; Garas, G.; MacQuillan, G.; Speers, D.; Jeffrey, G. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin. Chem. 2003, 49 (3), 450-454.